Project Grant R01CA289551
Award Date
9/4/24
Completion Date
8/31/29
Dollars Obligated
$661K
Federal Agency
National Cancer Institute
Federal Grant Program
93.393
Assistance Type
Project Grant
Place of Performance
Ohio, USA
Similar Awards
This $773,359 federal Project Grant award, funded by the National Institutes of Health (NIH) under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077), will support a randomized controlled trial to evaluate the effectiveness of nicotine pouches as a cigarette substitute. The University of Wisconsin-Madison will conduct this 5-year research study to assess how readily smokers will adopt nicotine pouches, how effectively pouches can substitute for...
The federal Project Grant award R01CA298165 was provided by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program. The $625,201 award will fund a 5-year randomized factorial trial to evaluate the combined impact of varenicline, nicotine lozenges, and a smartphone-based medication adherence intervention on smoking cessation outcomes among 496 adult daily smokers. The study aims to improve smoking cessation treatment and reduce cancer risk. A...
This Project Grant award of $622,957 from the National Institutes of Health (NIH) Office of the Director, under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077), supports research by Duke University to investigate the chemical composition and behavioral effects of novel tobacco products, including oral nicotine pouches and "non-menthol" cigarettes. The study aims to analyze the flavors, sweeteners, and nicotine forms in these products, and...
This Project Grant award from the National Cancer Institute (NCI), under the federal Cancer Cause and Prevention Research program (CFDA 93.393), will support a hybrid effectiveness-implementation trial to evaluate a novel harm reduction approach for oncology outpatients who smoke but refuse traditional tobacco treatment. The $619,175 award, effective December 1, 2024, will be used by the Medical University of South Carolina to directly compare rates of switching from cigarettes to e-cigarettes...
This Project Grant award from the National Institute on Minority Health and Health Disparities (CFDA 93.307 - Minority Health and Health Disparities Research) will evaluate population-based strategies for improving smoking cessation among rural residents. The key focus is to determine the efficacy of providing a free nicotine replacement therapy (NRT) starter kit, along with digital NRT education, to rural people who smoke. The $694,771 award to the Regents of the University of Minnesota will...
The National Cancer Institute (NCI) awarded a $371,822 Project Grant under CFDA 93.393 - Cancer Cause and Prevention Research to Rutgers, The State University of New Jersey on February 1, 2025. The grant will fund a series of complementary studies to characterize changes in cigar pack size over time and assess its impact on sales, consumption, and patterns of use using secondary data. Additionally, the project will examine how pack size, price, and flavor affect product preferences among diverse...
This $279,573 federal Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) aims to refine and test a novel biobehavioral smoking cessation intervention that integrates the strategic application of olfactory stimulation (OS) to reduce cigarette craving. The project will be conducted in two phases: Phase I will involve a crossover, micro-randomized controlled trial with 32 treatment-seeking smokers to refine the design...
This Project Grant award from the National Cancer Institute (NCI), under the federal Cancer Cause and Prevention Research program (CFDA 93.393), provides $515,632 to the Regents of the University of Minnesota to conduct research aimed at ensuring the U.S. is fully prepared to maximize smoking cessation during and following the implementation of proposed cigarette product standards by the U.S. Food and Drug Administration (FDA). The key objectives of this 3-year project are to: 1) Estimate, for...
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 Cancer Cause and Prevention Research) provides $687,995 to Yale University to conduct a randomized clinical trial investigating the efficacy of varenicline for quitting e-cigarette use in adults. The 5-year project aims to: 1) compare the effect of varenicline vs. placebo on e-cigarette quit rates, 2) test predictors and moderators of outcomes, and 3) explore changes in cancer-related biomarkers following...
This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $757,913 to the Fred Hutchinson Cancer Center in Seattle, WA to conduct a randomized controlled trial assessing the efficacy and cost-effectiveness of providing Hispanic adults who smoke with a smoking cessation smartphone app (iCanQuit) alone versus the app combined with free nicotine replacement therapy. The goal is to determine whether the addition of free nicotine...